LSP eyes up to €150m for new fund to battle rising global dementia cases
European life science investor LSP has launched a dedicated fund targeting the fight against neurodegenerative diseases. The LSP Dementia Fund will be managed by Professor Philip Scheltens, a world-renowned dementia scientist and thought leader, the firm
